Sign up for a new account.
And get access to
The latest T1D content
Research that matters
Our daily questions
Sign up by entering your info below.
Reset Your Password
We will email you instructions to reset your
We have a new study published from our work with the T1D Exchange Quality Improvement Collaborative (QIC) which examines the adoption of telehealth for type 1 diabetes (T1D) care during the COVID-19 pandemic.
In this study, we assess the use of telehealth visits (video or telephone) across the T1D Exchange QIC clinics between December 2019 and August 2020.
The percentage of virtual care visits in QIC clinics before the pandemic was less than 1%, rising to an average of 95.2% in April 2020. By August 2020, the proportion of telehealth visits decreased to an average of 45% across the QIC.
This study highlights the rapid adoption of virtual care in clinics during the pandemic. With these results, future discussion and research topics include insurance reimbursement for telehealth visits, and the ideal ratio of virtual to in-person visits in T1D care.
Read the Full Study: https://www.liebertpub.com/doi/10.1089/dia.2021.0080
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Join our mailing list for more about T1D
- An Interview with Dr. Enrique Caballero: Providing Culturally-Oriented Care to the Latinx Communityby Taylor DennisOctober 14, 2021
- Dr. Osagie Ebekozien Awarded ISPAD’s Prize for Innovation in Pediatric Diabetes Careby Sarah TackettOctober 13, 2021
- T1D Exchange Research Highlights from ISPAD 2021by Sarah TackettOctober 13, 2021
- Status Update: Connected Insulin Delivery Devicesby Hope WarshawOctober 7, 2021
- Top Questions of the Day – September 2021by Sarah TackettSeptember 30, 2021